Shandong Wohua Pharmaceutical Co., Ltd.

002107

CNE000001QB8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-09 EDT			5-day change	1st Jan Change
4.99 ^CNY	-1.77%		+3.53%	-17.79%

04-26	Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-29	Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shandong Wohua Pharmaceutical Co., Ltd. Approves Dividend for the Year 2021, Payable on March 8, 2022

February 11, 2022 at 02:36 pm

Shandong Wohua Pharmaceutical Co., Ltd. announced that at the Annual General Meeting held on 10 February 2022, approved cash dividend for 2021 of CNY 2.60000000 per ten shares (tax included). Record date: 07 March 2022, Ex-date: 08 March 2022 and Payment date: 08 March 2022.

Latest news about Shandong Wohua Pharmaceutical Co., Ltd.

Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-28	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-15	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-15	CI
Shandong Wohua Pharmaceutical Co., Ltd. Announces Executive Appointments	22-02-11	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-01-20	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-29	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-06	CI
Beijing Tongfengtang Pharmaceutical Management Co., Ltd. cancelled the acquisition of Wohua Pharmaceutical International Co., Ltd. from Shandong Wohua Pharmaceutical Co., Ltd..	21-03-26	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-01-20	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-15	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-07-15	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-28	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-28	CI
Beijing Tongfengtang Pharmaceutical Management Co., Ltd. entered into a share transfer agreement to acquire Wohua Pharmaceutical International Co., Ltd. from Shandong Wohua Pharmaceutical Co., Ltd. for CNY 90 million.	20-03-27	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-28	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-28	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-04-28	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	19-01-31	CI
Shandong Wohua Pharmaceutical Co., Ltd. Announces Earnings Results for the Third Quarter and Nine Months Ended September 2015	15-10-09	CI

Chart Shandong Wohua Pharmaceutical Co., Ltd.

Duration

Period

Chart Shandong Wohua Pharmaceutical Co., Ltd.

More charts

Company Profile

Shandong Wohua Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of Chinese traditional patent medicines. The Company's main products consist of Xinkeshu tablets for the treatment of coronary heart disease; Gushu tablets for the treatment of middle-aged and senile osteoporosis, and Hedan tablets for promoting blood circulation and for the treatment of hyperlipidemia. The Company distributes its products in domestic market, mainly in East China, North China and Northeast China.

Sector

Pharmaceuticals

Calendar

2024-05-15 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
SHANDONG WOHUA PHARMACEUTICAL CO., LTD.	-17.79%	399M
DONG-E-E-JIAO CO.,LTD.	+40.09%	6.16B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-16.34%	4.46B
TASLY PHARMACEUTICAL GROUP CO., LTD	-7.11%	3.27B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+5.14%	3.2B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-0.18%	2.6B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.93%	1.98B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.15%	1.7B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.67%	1.66B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-8.73%	1.61B

Alternative Medicine